We will invite experts who are at the forefront of regenerative medicine, biopharmaceuticals, and immune cell research to discuss the latest research information and future possibilities.
We will invite experts who are at the forefront of research on regenerative medicine, biopharmaceuticals, and clinical iPS cell extracellular vesicles using cultured cells to share the latest research information and future possibilities. Since this is a live broadcast, please be sure to register so you don't miss it. 【Nova Advanced Cell Science Seminar 2020 - The Future Opened by Cultured Cells】 ■ Date and Time: September 29, 2020 (Tuesday) 1:00 PM - 5:00 PM ■ Online live broadcast ■ Participation Fee: Free (Pre-registration required) (Organized by Nova Biomedical Corporation) ------------------------------------------------------------------------------------ ◆◆ Details & Registration ◆◆ https://www2.novabio.us/jp_seminar2020 ------------------------------------------------------------------------------------
Inquire About This Product
basic information
<<Introduction of Speakers (in order of presentation)>> ■Past and Future of Animal Cell Culture Dr. Kenji Omasa | Professor, Osaka University Graduate School ■Current Status and Challenges of EVs Therapy Dr. Takahiro Ochitani | Professor, Tokyo Medical University ■Production and Quality Control of Clinical iPS Cells Dr. Masayoshi Tsukahara | CiRA, Kyoto University Institute for Advanced Study ■Utilization of Analytical Techniques in Cell Manufacturing Dr. Masahiro Kinooka | Professor, Osaka University Graduate School Cooperating Company Session: Sartorius Stedim Japan K.K. Manufacturer Session: Nova Biomedical Corporation
Price range
Delivery Time
Applications/Examples of results
catalog(5)
Download All Catalogs
![[Verification Material] The Importance of Analyzing Culture Medium Components in iPS Cell Cultivation](https://image.mono.ipros.com/public/catalog/image/01/38c/440458/IPROS56142213031488853103.jpeg?w=120&h=170)
News about this product(1)
Company information
Nova Biomedical Corporation is a bio-medical company headquartered in Boston, USA. Since the development of the ionized calcium sensor in 1978, we have successfully commercialized innovative biosensors and have been providing innovative products that reflect the needs of medical settings and clinical research fields to this day. Our "automated analysis system for cell culture environments" supports research in fields such as "regenerative medicine" and "gene drug discovery." In the fortunate environment known as "Boston Bio Valley," we leverage cutting-edge science and technology to deliver better products to doctors, nurses, technicians, and researchers, continuously challenging ourselves to innovate. We have provided innovative products that reflect the needs of medical settings up to the present day. We will continue to support healthcare professionals and researchers to provide solutions as quickly as possible to patients suffering from difficult diseases. Our company has over 1,000 employees, with sales and service subsidiaries in eight countries and distributors in more than 90 countries. Nova Biomedical's products are being adopted worldwide.